======= CDCA2 ======= == Gene Information == * **Official Symbol**: CDCA2 * **Official Name**: cell division cycle associated 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=157313|157313]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q69YH5|Q69YH5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDCA2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDCA2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618785|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulator of chromosome structure during mitosis required for condensin-depleted chromosomes to retain their compact architecture through anaphase. Acts by mediating the recruitment of phopsphatase PP1-gamma subunit (PPP1CC) to chromatin at anaphase and into the following interphase. At anaphase onset, its association with chromatin targets a pool of PPP1CC to dephosphorylate substrates. {ECO:0000269|PubMed:16492807, ECO:0000269|PubMed:16998479}. No Pfam Domain information is available for this gene. |positive regulation of protein dephosphorylation| |positive regulation of dephosphorylation| |chromosome| |regulation of protein dephosphorylation| |regulation of dephosphorylation| |chromosome segregation| |cell division| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of protein modification process| |cell cycle| |positive regulation of cellular protein metabolic process| |positive regulation of protein metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.58| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.43| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-2.03| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.01| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-1.98| |[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|-1.83| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.81| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-1.75| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|1.95| |[[:results:exp93|DABN racemic mixture R03 exp93]]|3.22| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|3.69| ^Gene^Correlation^ |[[:human genes:t:tacc3|TACC3]]|0.52| |[[:human genes:d:dlgap5|DLGAP5]]|0.489| |[[:human genes:e:esco2|ESCO2]]|0.441| |[[:human genes:g:gsg2|GSG2]]|0.421| |[[:human genes:f:fntb|FNTB]]|0.403| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16318 * **Expression level (log2 read counts)**: 6.49 {{:chemogenomics:nalm6 dist.png?nolink |}}